## OTIS: Otis Worldwide Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -0.9% below STRENGTH zone (3.0-6.0%); PEG 2.17 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($84.46)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Otis Worldwide’s Strategic Shift: Can High-Margin Services Offset Market Headwinds?**
- Source: Primary Ignition | 20251219T200826 | Neutral | Relevance: 100%
- Otis Worldwide is focusing on high-margin, digitally-enabled service offerings and optimizing its balance sheet through strategic moves like a luxury contract in Kuala Lumpur and a sale-leaseback transaction. The company aims to counter persistent weakness in new equipment sales, particularly in China, through these initiatives and cost-reduction goals. Investors are watching for the upcoming earnings report on February 4, 2026, to assess the effectiveness of this strategy in driving service segment organic growth and alleviating margin pressure.

**2. Corient Private Wealth LLC Cuts Holdings in Otis Worldwide Corporation $OTIS**
- Source: MarketBeat | 20251218T090840 | Neutral | Relevance: 100%
- Corient Private Wealth LLC reduced its stake in Otis Worldwide Corporation by 6.5%, selling 11,567 shares and retaining 166,758 shares valued at approximately $16.51 million. This comes as Otis reported strong quarterly earnings, beating expectations with an EPS of $1.05, and sets FY2025 guidance at $4.040-$4.080 EPS. Despite some insider selling, institutional investors hold a significant majority of the company's stock.

**3. Analysts Offer Insights on Industrial Goods Companies: Frontier Group Holdings (ULCC), Otis Worldwide (OTIS) and Grupo Aeromexico, S.A.B. de C.V. Unsponsored ADR (AERO)**
- Source: The Globe and Mail | 20251218T120920 | Neutral | Relevance: 82%
- Barclays analysts have issued new ratings for several industrial goods companies. Brandon Oglenski maintained a Buy rating on Frontier Group Holdings (ULCC) with a $6.00 price target. Julian Mitchell maintained a Sell rating on Otis Worldwide (OTIS) with a $92.00 price target, and Pablo Monsivais maintained a Buy rating on Grupo Aeromexico (AERO) with a $27.00 price target, which aligns with J.P. Morgan's recent Buy initiation.

**4. 4D Molecular Therapeutics Announces Positive Interim Clinical Data from 4D-710 Aerow Phase 1 Clinical Trial in Cystic Fibrosis Lung Disease**
- Source: marketscreener.com | 20251217T181058 | Neutral | Relevance: 63%
- 4D Molecular Therapeutics reported positive interim clinical data from its 4D-710 Phase 1 AEROW trial for cystic fibrosis lung disease. The 2.5E14 vg dose cohort showed clinically meaningful activity in multiple endpoints, including ppFEV1, LCI2.5, and quality of life, confirming 2.5E14 vg as the Phase 2 dose. The company aims to complete enrollment for the Phase 2 Dose-Expansion cohort in the first half of 2026, with an update expected in the second half of 2026.

**5. NextPlat’s Global Telesat expands IoT portfolio with Telit Cinterion deal By Investing.com**
- Source: Investing.com Nigeria | 20251217T120942 | Somewhat-Bullish | Relevance: 62%
- NextPlat Corp's subsidiary Global Telesat Communications (GTC) has partnered with Telit Cinterion to enhance its Internet of Things (IoT) product offering, adding advanced 5G connectivity to its existing satellite and terrestrial services. This collaboration aims to boost GTC's presence in various industrial and enterprise IoT sectors. The global IoT market is projected to grow significantly, reaching approximately $2.65 trillion by 2030, presenting a substantial opportunity for the expanded portfolio.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Wells Fargo | $92 | $95 | -3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Wells Fargo | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 2 ($0.88M) |
| Sells | 3 ($0.68M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+0.1%)
- Blackrock Inc.: 8.2% (-1.3%)
- Alliancebernstein L.: 4.3% (-12.6%)
- State Street Corpora: 4.1% (-0.2%)
- JPMORGAN CHASE & CO: 3.9% (-32.0%)

### Key Risks

1. Long-term trend broken: trading 6.6% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.17 elevated, pricing in significant growth expectations. Quality metrics strong (ROA 14%). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bearish (5 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $34.2B |
| Beta | 1.01 |
| 52W Range | $84.25 - $106.83 |
| Short Interest | 2.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.17 |
| Forward P/E | 19.4 |
| Current P/E | 21.4 |
| YoY Growth | 10.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 3.2% to -0.9% (-4.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.9pp (needs >3.0% for momentum thesis). Below SMA200 (0.93x), long-term trend not supportive. RSI neutral at 44. OFD pattern: -DBH (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.86% (CS: 38) | Neutral |
| RSI_14 | 43.7 | Neutral |
| MACD Histogram | 0.14 | Bullish |
| vs SMA20 | 0.993x | Below |
| vs SMA50 | 0.973x | Below |
| vs SMA200 | 0.934x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $87.08
- **Stop Loss:** $84.46 (3.0% risk)
- **Target:** $89.70 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 343
- **Position Value:** $29,868.44
- **Portfolio %:** 29.87%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-01-28 (Est: $1.03)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.00 | $1.05 | +4.7% |
| 2025Q2 | $1.03 | $1.05 | +2.1% |
| 2025Q1 | $0.91 | $0.92 | +1.1% |
| 2024Q4 | $0.96 | $0.93 | -2.8% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*